← back to search

Jie Mo

Ministry of Education of the People's Republic of China · CN
🔎 Find collaborators in Molecular Biology · Complementary and alternative medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Molecular Biology · Complementary and alternative medicine
Research interest
Research topics from publications: The RNA m6A writer WTAP in diseases: structure, roles, and mechanisms; Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets; Critical roles of FAM134B in ER-phagy and diseases; USP11 potentiates HGF/AKT signaling and drives metastasis in hepatocellular carcinoma; DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma; The role of YAP1 in liver cancer stem cells: proven and potential mechanisms; MTDH-stabilized DDX17 promotes tumor initiation and progression through interacting with YB1 to induce EGFR transcription in Hepatocellular Carcinoma; GRAMD4 inhibits tumour metastasis by recruiting the E3 ligase ITCH to target TAK1 for degradation in hepatocellular carcinoma; DEAD‐Box Helicase 17 exacerbates non‐alcoholic steatohepatitis via transcriptional repression of cyp2c29, inducing hepatic lipid metabolism disorder and eliciting the activation of M1 macrophages; SP1‐activated USP27X‐AS1 promotes hepatocellular carcinoma progression via USP7‐mediated AKT stabilisation. Representative work: Abstract N6-methyladenosine (m 6 A) is a widely investigated RNA modification in studies on the “epigenetic regulation” of mRNAs that is ubiquitously present in eukaryotes. Abnormal changes in m 6 A levels are closely related to the regulation of RNA metabolism, heat shock stress, tumor occurrence, and development. m 6 A modifications are catalyzed by the m 6 A writer complex, which contains RNA methyltransferase-like 3 (METTL3), methyltransferase-like 14 (METTL14), Wilms tumor 1-associated protein (WTAP), and other proteins with methyltransferase (MTase) capability, such as RNA-binding motif protein 15 (RBM15), KIAA1429 and zinc finger CCCH-type containing 13 (ZC3H13). Although METTL3 is th Integrinβ-1 (ITGB1) is a crucial member of the transmembrane glycoprotein signaling receptor family and is also central to the integrin family. It forms heterodimers with other ligands, participates in intracellular signaling and controls a variety of cellular processes, such as angiogenesis and the growth of neurons; because of its role in bidirectional signaling regulation both inside and outside the membrane, ITGB1 must interact with a multitude of substances, so a variety of interfering factors can affect
h-index
citations
0
works
0
NIH funding
primary concept
email

Recent publications

Integrinβ-1 in disorders and cancers: molecular mechanisms and therapeutic targets
Cell Communication and Signaling 2024cited by 72position: middledoi
DEAD‐Box Helicase 17 exacerbates non‐alcoholic steatohepatitis via transcriptional repression of cyp2c29, inducing hepatic lipid metabolism disorder and eliciting the activation of M1 macrophages
Clinical and Translational Medicine 2024cited by 12position: middledoi
SP1‐activated USP27X‐AS1 promotes hepatocellular carcinoma progression via USP7‐mediated AKT stabilisation
Clinical and Translational Medicine 2024cited by 11position: middledoi
USP11 potentiates HGF/AKT signaling and drives metastasis in hepatocellular carcinoma
Oncogene 2023cited by 26position: middledoi
The RNA m6A writer WTAP in diseases: structure, roles, and mechanisms
Cell Death and Disease 2022cited by 142position: middledoi
The role of YAP1 in liver cancer stem cells: proven and potential mechanisms
Biomarker Research 2022cited by 20position: middledoi
MTDH-stabilized DDX17 promotes tumor initiation and progression through interacting with YB1 to induce EGFR transcription in Hepatocellular Carcinoma
Oncogene 2022cited by 19position: middledoi
GRAMD4 inhibits tumour metastasis by recruiting the E3 ligase ITCH to target TAK1 for degradation in hepatocellular carcinoma
Clinical and Translational Medicine 2021cited by 14position: middledoi
Critical roles of FAM134B in ER-phagy and diseases
Cell Death and Disease 2020cited by 68position: firstdoi
DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma
Journal of Experimental & Clinical Cancer Research 2019cited by 24position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bixiang Zhang · Wuhan Institute of Technology8 papers (2019–2024)Jin Chen · Zhengzhou University of Light Industry5 papers (2019–2023)Zhibin Liao · Ministry of Education of the People's Republic of China4 papers (2022–2024)Xiaoping Chen · Ministry of Education of the People's Republic of China4 papers (2019–2024)Ning Deng · Ministry of Education of the People's Republic of China4 papers (2019–2024)Huifang Liang · Academy of Medical Sciences4 papers (2019–2024)Qiumeng Liu · Ministry of Education of the People's Republic of China3 papers (2019–2023)Wanguang Zhang · Ministry of Education of the People's Republic of China2 papers (2023–2024)Su Chen · KU Leuven2 papers (2024–2024)Qibo Huang · Ministry of Education of the People's Republic of China2 papers (2022–2024)Lei Xu · Shihezi University2 papers (2022–2024)Pengcheng Du · Nanchang University2 papers (2019–2023)Ning Deng · Shanghai University1 papers (2022–2022)Qiaofeng Zhang · Nanjing University of Chinese Medicine1 papers (2022–2022)Hanhua Dong · Huazhong University of Science and Technology1 papers (2022–2022) · 1 papers (2019–2019)Peng Zhu · Wuhan Institute of Technology1 papers (2024–2024)Jin Chen · Nantong University1 papers (2024–2024)Peng Du · Soochow University1 papers (2021–2021) · 1 papers (2021–2021)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Molecular Biology · Complementary and alternative medicine →